David Adlington is ranked #2009 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/David Adlington

JPM

David Adlington

Q: How accurate are David Adlington's stock ratings?

About 60% of David's ratings were profitable over a one-year hold, with an average return of +0.8% per rating, measured by 13Foresight from historical prices.

J.P. Morgan

Wall Street Analyst

★★★☆☆

#2009

on 13Foresight · ranked by our own returns

60%

Success Rate

+0.8%

Average Return

25 of 42 calls profitable · -9.8% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 60% of David Adlington's ratings turned a profit when each position was held for 1 year — averaging +0.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

39 Buy 17 Hold 27 Sell

David's Stock Coverage 27 ratings · 2026-08-13

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
GB:SN Smith & Nephew	Aug 06, 2026	HOLD	Buy +1245.9% avg upside 16 analysts	$1290.00 18.07% Upside	·	·
DE:AFX Carl Zeiss Meditec	Aug 06, 2026	SELL	Sell +55.2% avg upside 13 analysts	$21.70 27.16% Downside	·	·
DE:FRE Fresenius SE & Co. KGaA	Aug 05, 2026	BUY	Strong Buy +8.9% avg upside 20 analysts	$55.20 17.84% Upside	+0.0%	·
DE:SHL Siemens Healthineers AG	Aug 04, 2026	BUY	Buy +25.8% avg upside 24 analysts	$57.40 47.09% Upside	-0.4%	·
DE:FME Fresenius Medical Care AG & Co. KGaA	Aug 03, 2026	SELL	Hold +21.8% avg upside 23 analysts	$37.40 8.88% Downside	-1.0%	·
DE:GXI Gerresheimer	Jul 29, 2026	BUY	Buy +128.9% avg upside 16 analysts	$46.00 69.05% Upside	-4.9%	·
IT:AMP Amplifon S.p.A.	Jul 28, 2026	BUY	Buy +96.2% avg upside 13 analysts	$16.70 36.48% Upside	+3.0%	·
NL:PHIA Koninklijke Philips N.V.	Jul 28, 2026	HOLD	Buy +30.7% avg upside 21 analysts	$23.50 1.43% Upside	+0.8%	·
GB:CTEC ConvaTec	May 22, 2026	BUY	Strong Buy +27.1% avg upside 18 analysts	$294.00 26.02% Upside	+12.7%	·
CH:SOON Sonova Holding AG	May 19, 2026	HOLD	Hold -6.8% avg upside 18 analysts	$189.00 21.34% Downside	+18.0%	·
FR:BIM bioMerieux	Apr 24, 2026	HOLD	Buy +34.7% avg upside 12 analysts	$71.60 2.00% Downside	+3.1%	·
WILLF Demant	Feb 04, 2026	BUY	Buy -6.0% avg upside 19 analysts	$38.58 14.01% Downside	+18.6%	·
SE:EKTA.B Elekta AB	Dec 08, 2025	SELL	Strong Sell +15.1% avg upside 12 analysts	$52.00 0.61% Downside	+7.6%	·
CH:ALC Alcon	Aug 21, 2025	HOLD	Strong Buy +20.1% avg upside 35 analysts	$62.92 6.25% Upside	-13.8%	·
CH:STMN Straumann Holding AG	Aug 14, 2025	HOLD	Buy +23.1% avg upside 15 analysts	$125.00 21.74% Upside	+9.8%	·
GB:SPI Spire Healthcare	Aug 05, 2025	BUY	Strong Buy +27.5% avg upside 6 analysts	$303.00 31.66% Upside	+13.0%	·
SE:GETI.B Getinge	Jul 21, 2025	SELL	Hold -1.2% avg upside 8 analysts	$165.00 31.12% Downside	-26.6%	·
GB:0K9P GN Store Nord	May 02, 2025	HOLD	Hold +140.0% avg upside 13 analysts	$135.00 35.04% Upside	+10.2%	·
SONVY Sonova Holding AG	Dec 03, 2024	SELL	Strong Sell +367.1% avg upside 1 analyst	$275.99 367.11% Upside	+24.6%	·
PHG Koninklijke Philips	Dec 20, 2023	SELL	Buy +35.1% avg upside 13 analysts	$20.64 22.98% Downside	-9.3%	·
AMBFF Ambu	Nov 09, 2023	SELL	Buy +1.8% avg upside 2 analysts	$7.25 33.14% Downside	-86.0%	·
CH:MOVE Medacta Group SA	Mar 30, 2023	HOLD	Buy +2.6% avg upside 5 analysts	$93.00 29.21% Downside	+23.7%	·
GB:0QBO Coloplast A/S	Jan 25, 2023	HOLD	Buy +67.8% avg upside 17 analysts	$800.00 82.87% Upside	-3.5%	·
FMS Fresenius Medical Care	Feb 04, 2021	HOLD	Hold +70.7% avg upside 15 analysts	$58.96 148.62% Upside	+4.8%	·
EKTAY Elekta AB	Aug 03, 2020	HOLD	Sell 2 analysts	—	+31.2%	·
FR:EL EssilorLuxottica SA	Oct 25, 2018	HOLD	Strong Buy +10.2% avg upside 17 analysts	$104.87 36.27% Downside	+13.9%	·
SNN Smith & Nephew Snats	Jan 25, 2018	BUY	Buy +12.8% avg upside 14 analysts	—	+3.8%	·

🔒 22 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

David Adlington — Frequently Asked Questions

How accurate are David Adlington's stock ratings?

Based on the calls 13Foresight could measure, about 60% of David's ratings were profitable over a one-year hold, with an average return of +0.8% per rating, or -9.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is David ranked on 13Foresight?

David Adlington is currently ranked #2009 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does David cover?

David most recently has ratings on GB:SN, DE:AFX, DE:FRE, DE:SHL, DE:FME, DE:GXI, IT:AMP, NL:PHIA, GB:CTEC, CH:SOON, FR:BIM, WILLF and 15 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

David Adlington

Rating Distribution

Welcome to 13Foresight!